This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

FINAL SAVINGS ENG IN

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
10 - 12 June, 2025
Congress CenterBasel Switzerland

Dr. Clarissa Whitehead, PhD
Senior Research Officer at Burnet Institute
Speaker

Profile

Clarissa is a Senior Research Officer in the Immune Therapies Group at the Burnet Institute and a co-inventor of Stellabody® technology - an innovative antibody engineering platform that enhances therapeutic potency by promoting on-target antibody hexamer formation.

Her research background spans both academic and commercial settings, from investigating disease progression in malignant glioma to leading antibody and exosome engineering projects supporting the development and commercialisation of novel therapeutics. With a strong focus on translational science that can shape the future of healthcare, Clarissa is passionate about advancing next-generation biologics to address unmet clinical needs and improve patient outcomes.

Agenda Sessions

  • Stellabody® Transforms Killing and Agonism Potency of Antibody and Ig-like Biologics

    10:00